Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: A phase 2 trial

Nitin Jain, James M. Reuben, Hagop Kantarjian, Changping Li, Hui Gao, Bang Ning Lee, Evan N. Cohen, Theresa Ebarb, David A. Scheinberg, Jorge Cortes

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: A phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences